Insider Transactions in Q1 2021 at Coherus Bio Sciences, Inc. (CHRS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 09
2021
|
Vladimir Vexler Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
114,240
-68.15%
|
$1,827,840
$16.25 P/Share
|
|
Mar 09
2021
|
Vladimir Vexler Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
102,480
+20.88%
|
$717,360
$7.14 P/Share
|
|
Mar 05
2021
|
Vincent R Anicetti Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
26,649
-17.99%
|
$399,735
$15.46 P/Share
|
|
Mar 05
2021
|
Vincent R Anicetti Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,312
+20.24%
|
$182,808
$9.3 P/Share
|
|
Feb 17
2021
|
Vincent R Anicetti Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,488
-4.0%
|
$42,296
$17.45 P/Share
|
|
Feb 17
2021
|
Vincent R Anicetti Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,488
+3.84%
|
$4,976
$2.5 P/Share
|
|
Feb 01
2021
|
Jean Frederic Viret Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,402
-10.77%
|
$155,442
$21.55 P/Share
|
|
Feb 01
2021
|
Jean Frederic Viret Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,402
+9.73%
|
$74,020
$10.05 P/Share
|
|
Jan 25
2021
|
Jean Frederic Viret Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
46,144
-23.17%
|
$876,736
$19.55 P/Share
|
|
Jan 25
2021
|
Jean Frederic Viret Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+27.13%
|
$400,000
$10.05 P/Share
|
|
Jan 19
2021
|
Vincent R Anicetti Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,500
-4.02%
|
$42,500
$17.94 P/Share
|
|
Jan 19
2021
|
Vincent R Anicetti Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+3.86%
|
$5,000
$2.5 P/Share
|
|
Jan 11
2021
|
Vincent R Anicetti Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+34.34%
|
-
|
|
Jan 11
2021
|
Jean Frederic Viret Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+31.67%
|
-
|
|
Jan 11
2021
|
Vladimir Vexler Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+32.42%
|
-
|
|
Jan 10
2021
|
Vincent R Anicetti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,080
-12.53%
|
$73,440
$18.18 P/Share
|
|
Jan 10
2021
|
Jean Frederic Viret Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,080
-10.13%
|
$73,440
$18.18 P/Share
|
|
Jan 10
2021
|
Vladimir Vexler Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,080
-10.74%
|
$73,440
$18.18 P/Share
|